IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 1 - 20 of 1182 stories.
December 19, 2014
Shareholders of GlaxoSmithKline (GSK) on Thursday approved by an overwhelming majoring a planned deal with Novartis, which sets the two pharma groups to trade more than $20.0 billion...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/GSK-shareholders-approve-$20-billion-asset-deal-with-Novartis_66362.html
December 19, 2014
Bayer HealthCare and Cardinal Health (Dublin, OH) have signed a 15-year agreement for the contract manufacturing of Bayer’s Xofigo (radium Ra 223 dichloride) drug. As part of the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Bayer-to-outsource-production-of-major-drug-to-Cardinal-Health_66360.html
December 17, 2014
UCB, Advent International and Avista Capital Partners said on Tuesday that they have agreed to terminate their agreement, announced on 7 November 2014, for Advent and Avista to acquire...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/UCB-terminates-agreement-to-sell-generic-drugs-unit-to-private-equity-groups_66235.html
December 12, 2014
Abbott has announced the completion of the purchase of Veropharm, a leading Russian pharmaceuticals manufacturer. Abbott announced in June that it acquired control of Veropharm for...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Abbott-completes-acquisition-of-Russian-pharma-firm_66144.html
December 11, 2014
Pharmaceuticals producer Cipla (Mumbai) has announced the sale its stake in Jiangsu Cdymax Pharmaceuticals for $18.5 million as part of a realignment of its global business. Cipla says...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cipla-sells-its-stake-in-Chinese-pharma-company_66077.html
December 9, 2014
Johnson Matthey acquires pharmaceutical ingredients facility in UK Johnson Matthey says that it has completed the acquisition of a pharmaceutical manufacturing facility at Annan, UK...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-9-December-2014_65988.html
December 8, 2014
Aurobindo Pharma (Hyderabad, India) said on Friday that it had completed acquiring assets of nutritional supplement maker Natrol and other affiliate entities through a wholly owned US...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Aurobindo-completes-acquisition-of-US-nutraceuticals-firm-Natrol_65943.html
December 8, 2014
Merck announced today that it has reached an agreement to acquire Cubist Pharmaceuticals (Lexington, MA) for $102/share in cash, which represents a 35% premium to Cubist’s...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-to-acquire-Cubist-Pharmaceuticals-for-$8-40-billion_65959.html
December 8, 2014
Sun Pharmaceutical Industries (Mumbai) and Ranbaxy Laboratories (Gurgaon, India) say that the Competition Commission of India (CCI; New Delhi) on 5 December approved Sun...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Competition-Commission-of-India-okays-Sun-Pharmas-acquisition-of-Ranbaxy_65964.html
December 8, 2014
Sanofi’s animal health subsidiary Merial is acquiring the Merck manufacturing facility at Barceloneta, Puerto Rico. The transaction is subject to approval by FTC. If approved...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sanofi-acquires-Mercks-animal-health-facility-in-Puerto-Rico_65950.html
December 5, 2014
Arbor Pharmaceuticals (Atlanta), a specialty pharmaceutical company, said on Thursday that private equity firm KKR is acquiring a “significant minority stake” in the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/KKR-acquires-stake-in-US-company-Arbor-Pharmaceuticals_65914.html
December 4, 2014
GlaxoSmithKline (GSK) has decided not to divest its mature drugs portfolio, the company said today. GSK announced in July that it had started a process to consider the divestment of...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/GlaxoSmithKline-scraps-plans-to-divest-mature-drugs-portfolio_65889.html
December 3, 2014
Johnson Matthey says that it has completed the acquisition of a pharmaceutical manufacturing facility at Annan, UK. The site, which was originally constructed by Glaxo in 1980, changed...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Johnson-Matthey-acquires-pharmaceutical-ingredients-facility-in-UK_65797.html
December 2, 2014
Bayer today said that it plans to sharpen its focus on innovation in its life science businesses, which include HealthCare and CropScience. “Overall, we expect the R&D to...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Bayer-outlines-R-and-D-plans-applies-for-nearly-500-life-sciences-patents_65771.html
December 2, 2014
Avanir Pharmaceuticals (Aliso Viejo, CA), a biopharmaceutical company focused on central nervous system (CNS) disorders, said today that it has entered into a definitive agreement with...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Otsuka-Pharmaceutical-to-acquire-Avanir-for-$3-5-billion_65770.html
December 2, 2014
Siegfried acquires German pharma firm Siegfried (Zofingen, Switzerland), a producer of active pharmaceutical ingredients (APIs), pharma intermediates, and finished drugs, says that it...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-2-December-2014_65769.html
December 1, 2014
Fine chemicals company Dottikon Exclusive Synthesis (Dottikon ES; Dottikon, Switzerland) reports a net loss of 3.20 million Swiss francs ($3.33 million) for its fiscal first half...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Dottikon-narrows-loss_65740.html
November 30, 2014
Merck KGaA (Darmstadt) hosted a top-level debate in London on Friday on key aspects of the over-the-counter (OTC) sector. The event, featuring contributions from leading analysts...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-KGaA-unveils-OTC-strategy-sparks-debate-on-the-sectors-future_65727.html
November 27, 2014
The US Federal Trade Commission (FTC) voted on Wednesday to approve GlaxoSmithKline’s (GSK) proposed acquisition of Novartis's vaccines business, excluding influenza vaccines...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/US-approves-GSK-Novartis-vaccines-and-consumer-healthcare-deals_65713.html
November 25, 2014
AbbVie acquires API facility in Singapore AbbVie (Chicago) say that it has acquired a small molecule active pharmaceutical ingredient (API) manufacturing site in Singapore's Tuas...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-25-November-2014_65671.html
Pages:  [1] 2 3 4 5 6 7 8 9 10 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa